Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

SYSTEMIC SCLEROSIS

Linking autoimmunity, short telomeres and lung fibrosis in SSc

Short telomere length is implicated in lung diseases and can be caused by mutations in telomere genes. Acquired autoimmunity directed against components of the telomere system is now reported in some patients with systemic sclerosis or idiopathic pulmonary fibrosis, suggesting a novel explanation for short telomeres in these diseases.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Potential origin and role of SSc-associated anti-telomere autoimmunity in short telomeres and ILD.

References

  1. Adler, B. L. et al. Autoantibodies targeting telomere-associated proteins in systemic sclerosis. Ann. Rheum. Dis. 80, 912–919 (2021).

    Article  CAS  Google Scholar 

  2. Grill, S. & Nandakumar, J. Molecular mechanisms of telomere biology disorders. J. Biol. Chem. 296, 100064 (2020).

    Article  Google Scholar 

  3. Stock, C. J. W. & Renzoni, E. A. Telomeres in interstitial lung disease. J. Clin. Med. 10, 1384 (2021).

    Article  CAS  Google Scholar 

  4. Khanna, D. et al. Etiology, risk factors, and biomarkers in systemic sclerosis with interstitial lung disease. Am. J. Respir. Crit. Care. Med. 201, 650–660 (2020).

    Article  CAS  Google Scholar 

  5. Silhan, L. L. et al. Lung transplantation in telomerase mutation carriers with pulmonary fibrosis. Eur. Respir. J. 44, 178–187 (2014).

    Article  CAS  Google Scholar 

  6. Lakota, K. et al. Short lymphocyte, but not granulocyte, telomere length in a subset of patients with systemic sclerosis. Ann. Rheum. Dis. 78, 1142–1144 (2019).

    Article  Google Scholar 

  7. Liu, T. et al. Telomerase and telomere length in pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol 49, 260–268 (2013).

    Article  CAS  Google Scholar 

  8. Weng, N. Interplay between telomere length and telomerase in human leukocyte differentiation and aging. J. Leukoc. Biol. 70, 861–867 (2001).

    CAS  PubMed  Google Scholar 

  9. Razdan, N., Vasilopoulos, T. & Herbig, U. Telomere dysfunction promotes transdifferentiation of human fibroblasts into myofibroblasts. Aging Cell 17, e12838 (2018).

    Article  Google Scholar 

  10. Newton, C. A. et al. Telomere length and use of immunosuppressive medications in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 200, 336–347 (2019).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John Varga.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lakota, K., Varga, J. Linking autoimmunity, short telomeres and lung fibrosis in SSc. Nat Rev Rheumatol 17, 511–512 (2021). https://doi.org/10.1038/s41584-021-00666-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41584-021-00666-3

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing